Results 161 to 170 of about 42,096 (271)

Occupational Asthma and Contact Urticaria in a Wildlife Worker With Type I Hypersensitivity to Deer Dander

open access: yes
Contact Dermatitis, Volume 94, Issue 6, Page 717-719, June 2026.
Eglė Janušonytė   +3 more
wiley   +1 more source

Healthcare Resource Utilization and Use of Biologics in Chronic Spontaneous Urticaria

open access: yesThe Journal of Dermatology, Volume 53, Issue 5, Page 832-836, May 2026.
ABSTRACT Biologic therapies have emerged as effective treatments for chronic spontaneous urticaria (CSU), a debilitating skin disease. However, real‐world data on their use are limited. This retrospective descriptive study analyzes the time from diagnosis to biologic therapy initiation and the CSU‐specific healthcare resource utilization (HCRU) among ...
Lillian D. Sun   +7 more
wiley   +1 more source

Revealing the Diverse Allergenic Protein Repertoire of Six Widely Consumed Crab Species: A Species‐Specific Allergen in King Crab

open access: yesAllergy, Volume 81, Issue 5, Page 1500-1521, May 2026.
This study comprehended the allergen profiles of six edible crab species using proteomic and transcriptomic analyses and identified 11 putative allergens. King crab has a distinct protein and allergen profile, with the discovery of malate dehydrogenase as a novel king crab‐specific allergen registered as Para c 11.
Shanshan Li   +11 more
wiley   +1 more source

Codfish Oral Immunotherapy in Children Aged 2–10: Randomized Placebo‐Controlled Study

open access: yesAllergy, Volume 81, Issue 5, Page 1799-1812, May 2026.
Codfish OIT significantly increased desensitization in children with fish allergy (43% vs. 11% placebo, p = 0.003), with 69% achieving 10‐fold threshold increases versus 26% in placebo (p = 0.0003). Sustained unresponsiveness remained limited (23% vs. 9%, p = 0.332). Treatment demonstrated acceptable safety with predominantly mild reactions and reduced
Agnes Sze‐yin Leung   +9 more
wiley   +1 more source

Transmission of F12-related hereditary angioedema through a sperm donor. [PDF]

open access: yesFront Immunol
Marquès L   +7 more
europepmc   +1 more source

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos   +16 more
wiley   +1 more source

Early Detection of Lower Adherence to Long‐Term e‐Diary Recording: A Checkpoint to Target Early Educational Intervention in Seasonal Allergic Rhinitis?

open access: yesClinical &Experimental Allergy, Volume 56, Issue 5, Page 526-537, May 2026.
Adherence to e‐Diary reporting was investigated in a blended care setting among pollen allergic patients with heterogeneous cultural backgrounds. A stable ‘higher’ and a more variable ‘lower’ adherence cluster were identified. Early identification of lower adherence is possible and might inform early interventions to improve patient adherence. ABSTRACT
S. Dramburg   +55 more
wiley   +1 more source

Real-world quality of life in patients with hereditary angioedema receiving lanadelumab or other long-term prophylaxis. [PDF]

open access: yesAllergy Asthma Proc
Davis-Lorton M   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy